Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115780) titled 'Long-term significant efficacy of gemcitabine combined with nedaplatin in persistent refractory nasopharyngeal carcinoma involving the cavernous sinus and distant metastasis:a case report' on Dec. 31, 2025.

Study Type: Observational study

Study Design: Case study

Primary Sponsor: The First Affiliated Hospital of Army Medical University

Condition: Nasopharyngeal carcinoma involving the cavernous sinus Pulmonary metastasis of nasopharyngeal carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-31

Target Sample Size: Case report:1;

Countries of Recruitment: China

To...